BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21645551)

  • 1. Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice.
    Kost S; Sun C; Xiong W; Graham K; Cass CE; Young JD; Albensi BC; Parkinson FE
    Behav Brain Res; 2011 Oct; 224(1):44-9. PubMed ID: 21645551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons.
    Parkinson FE; Xiong W; Zamzow CR; Chestley T; Mizuno T; Duckworth ML
    J Neurochem; 2009 Apr; 109(2):562-72. PubMed ID: 19222701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
    Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of functional nucleoside transporters in non-differentiated and differentiated human endothelial progenitor cells.
    Guzmán-Gutiérrez E; Sandoval C; Nova E; Castillo JL; Vera JC; Lamperti L; Krause B; Salomón C; Sepúlveda C; Aguayo C; Sobrevia L
    Placenta; 2010 Oct; 31(10):928-36. PubMed ID: 20728214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions.
    Zhang D; Xiong W; Albensi BC; Parkinson FE
    J Neurochem; 2011 Jul; 118(1):4-11. PubMed ID: 21395582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.
    Muñoz G; San Martín R; Farías M; Cea L; Vecchiola A; Casanello P; Sobrevia L
    J Cell Physiol; 2006 Dec; 209(3):826-35. PubMed ID: 16924660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium.
    Casanello P; Torres A; Sanhueza F; González M; Farías M; Gallardo V; Pastor-Anglada M; San Martín R; Sobrevia L
    Circ Res; 2005 Jul; 97(1):16-24. PubMed ID: 15933265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells.
    Guillén-Gómez E; Pinilla-Macua I; Pérez-Torras S; Choi DS; Arce Y; Ballarín JA; Pastor-Anglada M; Díaz-Encarnación MM
    J Cell Physiol; 2012 Apr; 227(4):1521-8. PubMed ID: 21678404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.
    Vega JL; Puebla C; Vásquez R; Farías M; Alarcón J; Pastor-Anglada M; Krause B; Casanello P; Sobrevia L
    Cardiovasc Res; 2009 Jun; 82(3):458-67. PubMed ID: 19193655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
    Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
    Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge.
    Rose JB; Naydenova Z; Bang A; Ramadan A; Klawitter J; Schram K; Sweeney G; Grenz A; Eltzschig H; Hammond J; Choi DS; Coe IR
    Life Sci; 2011 Oct; 89(17-18):621-30. PubMed ID: 21872611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference.
    Choi DS; Cascini MG; Mailliard W; Young H; Paredes P; McMahon T; Diamond I; Bonci A; Messing RO
    Nat Neurosci; 2004 Aug; 7(8):855-61. PubMed ID: 15258586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium.
    Puebla C; Farías M; González M; Vecchiola A; Aguayo C; Krause B; Pastor-Anglada M; Casanello P; Sobrevia L
    J Cell Physiol; 2008 Jun; 215(3):645-56. PubMed ID: 18064606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole.
    Endres CJ; Unadkat JD
    Mol Pharmacol; 2005 Mar; 67(3):837-44. PubMed ID: 15557207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
    Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
    J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-linked glycosylation of N48 is required for equilibrative nucleoside transporter 1 (ENT1) function.
    Bicket A; Coe IR
    Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27480168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters.
    Hammond JR; Archer RG
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1083-93. PubMed ID: 14634039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.
    Damaraju VL; Elwi AN; Hunter C; Carpenter P; Santos C; Barron GM; Sun X; Baldwin SA; Young JD; Mackey JR; Sawyer MB; Cass CE
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F200-11. PubMed ID: 17409283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of human equilibrative nucleoside transporter 1 by RNAi enhances 5-fluorouracil response in pancreatic cancer.
    Hu X; Chen W; Xu J
    Hepatogastroenterology; 2010; 57(104):1567-72. PubMed ID: 21443122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.